Whoop Expands to Women’s Health with Blood Test Launch in 2026

LONDON, March 10, 2026 — Fitness wearable company Whoop has unveiled a new blood testing panel aimed at addressing women's health, according to TechCrunch. The panel, part of the Whoop Labs service, includes 11 biomarkers designed to provide insights into hormonal changes and menstrual cycle regulation, alongside a new app feature to track hormonal fluctuations. This move marks a significant step in the intersection of wearable technology and personalized health care, particularly for women.

Executive Summary

• Whoop launches a women's health-focused blood testing service.
• The panel includes 11 biomarkers addressing hormonal and menstrual health.
• A new app feature tracks hormonal changes during menstrual cycles.
• Move signals a deeper integration of wearables with personalized health insights.

Key Developments

Whoop, the fitness technology company known for its advanced wearable devices, has announced the expansion of its health services with a new blood testing panel tailored specifically for women. For more on [related health tech developments](/microsoft-google-and-aws-advance-ehr-integration-as-health-tech-reconfigures-in-2026-22-01-2026). As reported by TechCrunch, the panel is part of the company's Whoop Labs service and is designed to provide critical insights into women’s hormonal health and menstrual cycles. The test measures 11 biomarkers: Anti-Müllerian Hormone (AMH), Progesterone, Prolactin, Thyroid Peroxidase Antibodies (TPOAb), Free T4, Free T3, Leptin, Vitamin B12, Folate, Magnesium, and Phosphate (as Phosphorus).

The company has also integrated a new feature into its app, which surfaces detailed information about hormonal changes during menstrual cycles. This addition aims to empower users with a deeper understanding of their physiological changes, aligning with Whoop’s broader mission to deliver personalized health insights through technology. By addressing specific health needs for women, the company positions itself as a key player in the evolving health tech space.

Market Context

Wearable technology is increasingly converging with personalized healthcare, a market expected to grow significantly in the coming years. According to market research firm Statista, the global wearable health tech market is projected to surpass $50 billion by 2028. Companies like Whoop are capitalizing on this trend by expanding their offerings to address niche health concerns, such as women’s hormonal health, which has historically been underrepresented in both healthcare innovation and wearable tech development.

Additionally, the focus on biomarkers in wearable tech represents a shift toward preventative care and early detection, aligning with broader industry trends. Competitors such as Fitbit and Garmin have also introduced health-oriented features, but Whoop’s targeted approach to women’s health could give it a competitive edge in a crowded market.

BUSINESS 2.0 Analysis

Whoop’s introduction of a women’s health-focused blood test and app feature reflects a broader evolution within the wearable tech industry. For more on [related health tech developments](/how-agentic-ai-reshaping-life-sciences-building-intelligent-health-system-9-december-2025). While fitness tracking has long been the primary use case for devices like Whoop, Fitbit, and Apple Watch, the integration of health diagnostics signals a shift toward holistic wellness management. This aligns with growing consumer demand for personalized healthcare solutions, particularly among women, a demographic that has historically been underserved in tech-driven health initiatives.

The inclusion of biomarkers such as Anti-Müllerian Hormone (AMH) and Progesterone highlights Whoop’s commitment to addressing complex health issues like cycle regulation and hormonal transitions. These metrics are not only relevant for general health but also carry implications for fertility tracking, a growing area of interest for younger, health-conscious consumers.

However, this move is not without challenges. The success of Whoop’s new offering will depend on its ability to ensure data accuracy, maintain user privacy, and navigate potential regulatory scrutiny. Moreover, competitors like Apple and Fitbit could respond with similar features, intensifying the race to dominate the women’s health tech space. Nonetheless, Whoop’s proactive approach positions it as a leader in the next wave of wearable technology innovation.

Why This Matters for Industry Stakeholders

For investors, Whoop’s latest move underscores its ambition to expand beyond fitness into broader health and wellness markets, particularly women’s health, which has long been underserved. This diversification could open new revenue streams and attract a more diverse customer base.

For healthcare providers, the integration of biomarker testing with wearable technology offers opportunities for early detection and improved patient outcomes. For more on [related health tech developments](/ai-cardiology-digital-disruptions-cardiovascular-care-2026-9-december-2025). However, it also raises questions about the reliability of consumer-grade health data and its integration with clinical workflows.

For competitors, Whoop’s foray into women’s health is a signal to innovate or risk losing market share. The wearable tech market is rapidly evolving, and companies that fail to address niche health concerns may struggle to remain relevant.

Forward Outlook

Looking ahead, Whoop’s expansion into women’s health could set a precedent for other wearable tech companies to follow. As the market for personalized health solutions continues to grow, we can expect increased competition and innovation in this space. Features like biomarker testing and app-based health tracking are likely to become standard across the industry.

However, regulatory challenges and consumer trust will be critical factors in determining the long-term success of such initiatives. Companies will need to ensure data accuracy and privacy while navigating complex healthcare regulations. As Whoop continues to expand its offerings, it will be crucial to monitor how competitors respond and whether the company can maintain its leadership position in the wearable health tech market.

Key Takeaways

• Whoop launches a women’s health-focused blood testing panel with 11 biomarkers.
• New app feature provides insights into hormonal changes during menstrual cycles.
• Move highlights the growing convergence of wearable tech and personalized healthcare.
• Whoop’s expansion could drive innovation and competition in the health tech sector.

References

1. TechCrunch
2. Statista
3. More Health Tech Coverage